NCT07101705
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
- Locations
-
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
Clinical trial condition
Non-Hodgkin Lymphoma (NHL)
Explore clinical trials studying Non-Hodgkin Lymphoma (NHL). Study availability and eligibility vary by location and protocol.
8 public trials
2 recruiting studies
Non-Hodgkin Lymphoma (NHL) trial results
NCT07312630
- Conditions
- Acute Lymphoblastic Leukemia (ALL), Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- PersonGen.Anke Cellular Therapeutice Co., Ltd. Hefei, Anhui, China
NCT02875548
- Conditions
- Adenoma, Advanced Solid Tumors, Diffuse Large B-Cell Lymphoma (DLBCL), +24 more
- Locations
-
- University of Arizona Cancer Center Tucson, Arizona, United States
- California Cancer Associates For Research And Excellence, cCARE Santa Fe, California, United States
- Hematology Oncology Associates of the Treasure Coast - Port St. Lucie Port Saint Lucie, Florida, United States
- Moffitt Tampa, Florida, United States
NCT04537715
- Conditions
- Adenoma, Advanced Malignancies, All Malignancies, +32 more
- Locations
-
- California Cancer Associates for Research and Excellence, Inc. (cCARE) Encinitas, California, United States
- The Angeles Clinic and Research Institute Los Angeles, California, United States
- Northwestern University-Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
- South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
NCT02265731
- Conditions
- Acute Myeloid Leukemia (AML), Blood Protein Disorders, Cardiovascular Diseases, +30 more
- Locations
-
- NHO Nagoya Medical Center /ID# 129222 Nagoya, Aichi-ken, Japan
- Aichi Cancer Center Hospital /ID# 129061 Nagoya, Aichi-ken, Japan
- Nagoya City University Hospital /ID# 129278 Nagoya, Aichi-ken, Japan
- University of Fukui Hospital /ID# 165801 Yoshida-gun, Fukui, Japan
Completed
Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level
NCT01396070
- Conditions
- Cutaneous Lymphoma, Cutaneous T-cell Lymphoma (CTCL), Hemic and Lymphatic Diseases, +13 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States
NCT01707628
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +14 more
- Locations
-
- Canisius Wilhelmina Hospital Nijmegen, Gelderland, Netherlands
- Onze Lieve Vrouwen Gasthuis Amsterdam, North Holland, Netherlands
- Medisch Spectrum Twente Enschede, Overrijssel, Netherlands
- Medisch Centrum Leeuwarden Leeuwarden, Provincie Friesland, Netherlands
NCT02790515
- Conditions
- Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Bone Marrow Diseases, +32 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States